The Vaccine Should Never have been Approved

RSM = Back in Full Force!

So now Joe Biden has conveniently come down with Covid again. Again! This is the man who has been poked with more vaccine and booster needles than an old woman's pin cushion, and he's had Covid a half dozen times. As if we needed any more evidence that this vaccine business is a scam. Maybe it didn't work in early 2021 because it was hurried and steps were skipped, but what is the excuse now 3 1/2 years later?

What a novel concept, natural immunity to a virus, or acquired immunity from having had it.  Why that would make Covid just like every other virus in human history.  Could it be that the vaccine is just an unchallenged opportunity for pharmaceutical companies to make tens of billions of dollars on the taxpayer dime by selling us snake oil?

I also noticed that "free" Covid test kits are no available to the public again.  Is Biden's infection and renewed testing the first step in making the November election "by mail only"?  If that happens, watch for Biden (or Harris) to be the first candidate in American history to get 400 million votes and beat Trump in a landslide.

Or, "I just caught the clap, but thank God I always wipe down my toilet seats".

The good old counterfactual arguments presented as facts and happily swallowed by the sheeple.

It would've been worse... Blah blah blah.

Only two industrialized countries currently allow direct-to-consumer advertising (DTCA) of prescription drugs on television:



The United States

New Zealand



These are the only two countries out of 195 in the world that permit pharmaceutical companies to advertise prescription medications directly to consumers through television commercials and other forms of advertising. All other industrialized nations prohibit this practice.

The United States has allowed DTCA of prescription drugs since 1997, when the FDA relaxed regulations on pharmaceutical advertising. New Zealand has permitted it since the 1980s. This unique situation has led to ongoing debate about the merits and risks of allowing prescription drug ads targeted at consumers. Proponents argue it can educate patients, while critics worry it may lead to inappropriate prescribing and higher drug costs.

The American Medical Association has even called for a ban on DTCA of prescription drugs in the U.S., citing concerns about its impact. The fact that only two countries permit this practice highlights how unusual and controversial direct-to-consumer pharmaceutical advertising remains globally. Most other nations restrict drug advertising to medical professionals only.